기본 콘텐츠로 건너뛰기

추천 가젯

[스크리너 톱600-514] 유바이오로직스 - 콜레라 백신 원툴, 조달가는 매년 낮아진다

밸류체인 플랫폼의 저평가 스크리너를 순서대로 뜯어보는 연재, 511~520번 구간입니다. 514번 유바이오로직스(206650). 기준일 2026-08-28, 스크리너 점수 56.5점 — 저평가 컷(67.2점)에 10.7점 모자란 '적정' 판정 입니다. 경구용 콜레라 백신으로 국제기구 조달시장을 잡은 회사 유바이오로직스는 경구용 콜레라 백신 '유비콜' 시리즈를 개발·생산하는 백신 전문기업이다. 춘천에 생산기지를 두고 있고, WHO 사전적격성평가(PQ) 인증을 받은 유비콜은 유니세프(UNICEF) 등 국제기구가 주관하는 글로벌 콜레라 백신 공공조달 시장에 공급된다. 매출의 절대 축이 이 조달 물량이라는 점이 이 회사를 이해하는 출발점이다. 코스닥 상장사다. 연도 매출(억원) 영업이익(억원) 순이익(억원) 2022 555 -38 -11 2023 694 77 -139 2024 960 343 191 2025 1,492 607 413 매출은 2022년 555억원에서 2025년 1,492억원으로 3년 만에 세 배 가까이 늘었고, 2022년 영업적자였던 손익은 2024년 흑자전환 뒤 2025년 영업이익 607억원(영업이익률 40.7%)까지 확대됐다. 순이익도 2024년 191억원, 2025년 413억원으로 규모가 커졌다 — 순이익이 영업이익보다 낮은 격차는 법인세 등 통상 수준으로, 별도의 일회성 요인은 확인되지 않는다. 시가총액 3,495억원, PER 12.0배·PBR 1.99배·ROE 16.7% (TTM). 제약/바이오 피어 72개 PER 중앙값(13.67배)보다 오히려 낮다 — 이 구간에서 흔한 "피어보다 비싼" 사례는 아니다. 왜 스크리너 514위인가 원점수 56.2(순위 중하위권)는 정규분포 정규화를 거쳐 59.8점이 됐는데, 이 값부터 이미 저평가 컷(67.2)에 7.4점 못 미친다. 여기에 소속 산업(제약/바이오)의 최근 6개월 수익률이 -31.6%로 순환매 밴드 하위에 들어 -5.0점 감...

CCUS and Geothermal Are Clearly Essential, but Monetization Is Still Moving Slowly

If you follow the carbon neutrality story long enough, you eventually come back to the same question: can renewables alone really solve everything? Reality is not that simple. To cut the carbon already being emitted from industrial processes and the power sector, the discussion increasingly converges on the need for CCUS—capturing carbon from areas where eliminating emissions outright is difficult, then storing it or putting it back to use. CCUS is not just an option for net zero; it is effectively the final piece of the puzzle.

The problem is the market’s timeline. The technology exists, and the policy language is becoming clearer, but there are very few pure-play listed names in the Korean stock market that investors can buy directly. To put it more bluntly, many are still at the demonstration, pilot, or government-backed R&D project stage. Geothermal is no different. In practice, the more realistic market is heating and cooling—more specifically heat pumps—rather than power generation, and in small hydropower, it is hard to find listed companies in Korea that offer pure exposure. The opportunity is promising, but it is not yet a segment where serious money is flowing. That gap needs to be acknowledged first.

CCUS (Carbon Capture & Utilization) — Still at the Demonstration Threshold (4 companies)

If you try to map CCUS to listed Korean stocks, there are more indirect plays than you might expect. Some companies own capture technologies directly, some stand to benefit through raw materials used in absorbents for carbon capture, and some have moved from air pollution control equipment into pilot-scale CO2 capture. For CCUS investing in Korea today, the key is less about “commercial revenue” and more about reading where companies stand in technology internalization and demonstration.

Doosan Enerbility has internalized wet amine-based CO2 capture technology for power plants after taking a technology transfer from KEPCO, and is pushing toward commercialization through MW-scale demonstration projects. That said, it is still hard to argue that meaningful revenue has kicked in. UNID is the global No. 1 player in caustic potash and potassium carbonate, and the link here is that potassium carbonate is used as a raw material for CO2 capture absorbents. But it is, at the end of the day, not a carbon capture operator but more of a raw-material beneficiary. KC Cottrell is one of Korea’s top players in air pollution control, including electrostatic precipitators, desulfurization, and denitrification, while its CO2 capture business remains at the 1 ton/day pilot stage. KPX Green Chemical is developing carbonate and CO2 utilization materials, but its core business is surfactants, and its CCU work is still at the government-backed R&D stage. The upside story is there, but the commercial story visible in the numbers is still limited.

CompanyCore focus · stage
Doosan EnerbilityInternalized wet (amine) CO2 capture technology for power plants (transferred from KEPCO) · linked to MW-scale demonstration — pursuing commercialization (pre-revenue)
UNIDGlobal No. 1 in caustic potash and potassium carbonate — potassium carbonate is a raw material for CO2 capture absorbents (not a capture business, but a raw-material beneficiary)
KC CottrellKorea top-tier in air pollution control including electrostatic precipitators, flue gas desulfurization (FGD), and selective catalytic reduction (SCR) (~70–80%) + CO2 capture pilot (1 ton/day)
KPX Green ChemicalCarbonates (EC/DMC) + CO2 utilization (CCU) materials — core business is surfactants (~95%), with CCU still at the government-backed R&D stage

Geothermal & Niche Renewables — A Small but Real Market (2 companies)

When it comes to geothermal and niche renewables, it’s even more important to separate the image the term evokes from the actual market. Geothermal may immediately bring power generation to mind, but in Korea the real business is much more clearly centered on heating and cooling design and construction using geothermal heat pumps. What about small hydro? It gets talked about a lot, but in the domestic stock market there are effectively no listed companies that offer pure-play exposure. Niche renewables like geothermal and small hydro may have a big narrative, but in Korea’s listed market, most exposure is indirect rather than through pure plays.

GNOne Energy is widely cited as a domestic leader in geothermal and hydrothermal heating and cooling—that is, geothermal heat pump design and construction. Its references, such as Lotte World Tower and the Sejong Government Complex, are also heating and cooling projects, not geothermal power generation. That distinction matters. Daemyung Energy is a company engaged in renewable power development, EPC, and O&M across wind, solar, and BESS, and it carries the symbolic distinction of being the first renewable-specialist company to list in 2022. It also discloses its operating scale, so the business has clear substance. Even so, like CCUS, this is not really a “next-generation demonstration” story, but something closer to an already existing renewable development and operations business.

CompanyCore focus · stage
GNOne EnergyDomestic leader in geothermal and hydrothermal heating/cooling (geothermal heat pump) design and construction — Lotte World Tower · Sejong Government Complex (heating/cooling, not geothermal power generation)
Daemyung EnergyRenewable power development, EPC, and O&M across wind, solar, and BESS — first renewable-specialist company to list in 2022 (operating ~278MW)

What to Watch Going Forward

The overall direction ahead is relatively clear. If net zero is a serious goal, CCUS will inevitably keep gaining traction, and as the energy transition in buildings and public infrastructure continues, heating and cooling solutions like geothermal heat pumps are also likely to be reassessed. That said, it would be a stretch to lump this space together as a single growth-stock theme right now. In Korea, there are only a handful of pure-play listed names, and even among them, many are still in the demonstration or early-stage phase. What really matters is not whether the technology exists, but when it actually translates into commercial revenue.

That is why this theme always demands both optimism and patience. Doosan Enerbility’s push to commercialize carbon capture technology, UNID’s exposure to absorbent raw materials, KC Cottrell’s pilot projects, KPX Green Chemical’s government-backed R&D programs, GNW Energy’s geothermal heating and cooling, and Daemyung Energy’s renewable operations capabilities each have their own significance. But this is still not the stage where you can say, “It looks promising, so it will make money right away.” The real thing to watch in this sector is not technology hype, but the moment commercialization timing and economic viability are proven in hard numbers.

※ This article organizes company names, core businesses, and technology stages based on publicly available materials verified on the web, and some assessments reflect the author’s own views. CCUS and geothermal remain in the early stages of commercialization and should not be taken as a direct basis for investment decisions.

Written: 2026. 7. Ealexandro

댓글

가장 많이 본 글